Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_assertion wasGeneratedBy ECO_0000203 NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_assertion wasDerivedFrom befree-20150227 NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_assertion SIO_000772 11781223 NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_assertion evidence source_evidence_literature NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.
- NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_assertion description "[A reliable and sensitive (10(-5)) real-time RT-PCR assay was set up for the evaluation of relevant CBFbeta-MYH11/ABL transcript ratios and was applied to the 21 patients with inv(16) AML routinely referred for cytogenetic and molecular monitoring in Seràgnoli Institute (Bologna, Italy) since 1990.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576950.RArok-b0qp3sxIuI_M1-jCt2-kPf_3L6-UeXvwREVokvY130_provenance.